BioSpace News Archive

OpGen, Inc. (Nasdaq: OPGN) reported an update on the business of Curetis GmbH (“Curetis”), the other party to the planned business combination with OpGen.

Chiesi USA, Inc. (key-A-zee) announced today that the company has been named as a Top Employer in the United States for the fifth consecutive year

The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center, one of the largest hyperbaric treatment centers in the world, today announced the results of a study that – for the first time in humans – demonstrates the positive, sustained effect of its hyperbaric oxygenation therapy (HBOT) protocols on heart function

Sperling Dermatology, LLC, headquartered in Florham Park, NJ achieved record breaking growth in 2019 and was officially recognized for several prestigious accomplishments by aesthetic industry leaders Allergan™ and BTL Aesthetics™.

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2019 fourth quarter and year-end financial results will be released on Thursday, February 13, 2020 after the market closes.

Healthfirst announced today that it is teaming with NationsHearing to provide an enhanced hearing health solution for its Medicare Advantage plan members, including Healthfirst CompleteCare (HMO SNP) plan members.

Georgia Bio, the state’s life science trade association, will celebrate its Golden Helix Awards & Annual Gala on Friday, March 13th at Factory Atlanta in Chamblee

Neogen Corporation (NASDAQ: NEOG) announced today that it and Angus Genetics, Inc. (AGI) have launched updated content to Angus GSSM — the first genomic profiler designed specifically for Angus cattle.

One World Pharma Inc. (OTCQB: OWPC), “OWP,” a fully licensed pure-play cannabis and hemp ingredient producer in Colombia, is pleased to announce the completion of a purchase order for the sale of 1.7 million characterized hemp seeds to CoProCannabis in Colombia.

Key Biologics, the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry, today announced it has hired two new executives to support its recent growth and ongoing demand for its products and services.